- Home
- COSO vs LYEL Comparison
COSO vs LYEL Comparison
Compare COSO & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COSO
- LYEL
- Stock Information
- Founded
- COSO 2003
- LYEL 2018
- Country
- COSO United States
- LYEL United States
- Employees
- COSO N/A
- LYEL N/A
- Industry
- COSO
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- COSO
- LYEL Health Care
- Exchange
- COSO NYSE
- LYEL Nasdaq
- Market Cap
- COSO 252.3M
- LYEL 207.7M
- IPO Year
- COSO N/A
- LYEL 2021
- Fundamental
- Price
- COSO $20.90
- LYEL $12.42
- Analyst Decision
- COSO
- LYEL Sell
- Analyst Count
- COSO 0
- LYEL 2
- Target Price
- COSO N/A
- LYEL $15.00
- AVG Volume (30 Days)
- COSO 40.1K
- LYEL 127.0K
- Earning Date
- COSO 08-05-2025
- LYEL 08-06-2025
- Dividend Yield
- COSO N/A
- LYEL N/A
- EPS Growth
- COSO 11.71
- LYEL N/A
- EPS
- COSO 2.31
- LYEL N/A
- Revenue
- COSO $74,066,000.00
- LYEL $65,000.00
- Revenue This Year
- COSO N/A
- LYEL N/A
- Revenue Next Year
- COSO N/A
- LYEL N/A
- P/E Ratio
- COSO $9.22
- LYEL N/A
- Revenue Growth
- COSO 11.05
- LYEL N/A
- 52 Week Low
- COSO $17.75
- LYEL $7.65
- 52 Week High
- COSO $22.68
- LYEL $34.90
- Technical
- Relative Strength Index (RSI)
- COSO N/A
- LYEL 67.30
- Support Level
- COSO N/A
- LYEL $9.11
- Resistance Level
- COSO N/A
- LYEL $9.83
- Average True Range (ATR)
- COSO 0.00
- LYEL 0.74
- MACD
- COSO 0.00
- LYEL 0.25
- Stochastic Oscillator
- COSO 0.00
- LYEL 84.54
About COSO COASTALSOUTH BANCSHARES INC
CoastalSouth Bancshares Inc is a bank holding company. It offers full-service banking services designed to meet the needs of retail and commercial customers in the markets in which it operates. The services offered include transaction and savings deposit accounts, commercial and consumer lending, mortgage banking, and other activities related to commercial banking. It operates nearly 11 retail banking branches in three retail main retail markets, the Lowcountry of South Carolina, Savannah, Georgia, and metro Atlanta, Georgia.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.